163 related articles for article (PubMed ID: 23886077)
1. New uses for old drugs: attempts to convert quinolone antibacterials into potential anticancer agents containing ruthenium.
Kljun J; Bratsos I; Alessio E; Psomas G; Repnik U; Butinar M; Turk B; Turel I
Inorg Chem; 2013 Aug; 52(15):9039-52. PubMed ID: 23886077
[TBL] [Abstract][Full Text] [Related]
2. DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.
Novakova O; Chen H; Vrana O; Rodger A; Sadler PJ; Brabec V
Biochemistry; 2003 Oct; 42(39):11544-54. PubMed ID: 14516206
[TBL] [Abstract][Full Text] [Related]
3. Ruthenium(II)/(III) complexes of 4-hydroxy-pyridine-2,6-dicarboxylic acid with PPh3/AsPh3 as co-ligand: impact of oxidation state and co-ligands on anticancer activity in vitro.
Kamatchi TS; Chitrapriya N; Lee H; Fronczek CF; Fronczek FR; Natarajan K
Dalton Trans; 2012 Feb; 41(7):2066-77. PubMed ID: 22183160
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, spectroscopic characterization, photochemical and photophysical properties and biological activities of ruthenium complexes with mono- and bi-dentate histamine ligand.
Cardoso CR; de Aguiar I; Camilo MR; Lima MV; Ito AS; Baptista MS; Pavani C; Venâncio T; Carlos RM
Dalton Trans; 2012 Jun; 41(22):6726-34. PubMed ID: 22539182
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, redox behavior, DNA and protein binding and antibacterial activity studies of ruthenium(II) complexes of bidentate schiff bases.
Paul H; Sen B; Mondal TK; Chattopadhyay P
Nucleosides Nucleotides Nucleic Acids; 2017 Aug; 36(8):520-542. PubMed ID: 28708465
[TBL] [Abstract][Full Text] [Related]
6. Cellular delivery of pyrenyl-arene ruthenium complexes by a water-soluble arene ruthenium metalla-cage.
Furrer MA; Schmitt F; Wiederkehr M; Juillerat-Jeanneret L; Therrien B
Dalton Trans; 2012 Jun; 41(24):7201-11. PubMed ID: 22506276
[TBL] [Abstract][Full Text] [Related]
7. Carbonyl-heterobimetallic Ru(II)/Fe(II)-complexes containing polypyridyl ligands: Synthesis, characterization, cellular viability assays and interactions with biomolecules.
Dávila-Rodríguez MJ; Barolli JP; de Oliveira KM; Colina-Vegas L; da Silva Miranda F; Castellano EE; Von Poelhsitz G; Batista AA
Arch Biochem Biophys; 2018 Dec; 660():156-167. PubMed ID: 30389443
[TBL] [Abstract][Full Text] [Related]
8. Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity.
Bratsos I; Jedner S; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E
J Inorg Biochem; 2008; 102(5-6):1120-33. PubMed ID: 18279961
[TBL] [Abstract][Full Text] [Related]
9. Differences in structure, physiological stability, electrochemistry, cytotoxicity, DNA and protein binding properties between two Ru(III) complexes.
Tan C; Liu J; Li H; Zheng W; Shi S; Chen L; Ji L
J Inorg Biochem; 2008 Feb; 102(2):347-58. PubMed ID: 18022241
[TBL] [Abstract][Full Text] [Related]
10. New 4'-(4-chlorophenyl)-2,2':6',2″-terpyridine ruthenium(II) complexes: Synthesis, characterization, interaction with DNA/BSA and cytotoxicity studies.
Milutinović MM; Rilak A; Bratsos I; Klisurić O; Vraneš M; Gligorijević N; Radulović S; Bugarčić ŽD
J Inorg Biochem; 2017 Apr; 169():1-12. PubMed ID: 28088012
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes.
Tan C; Liu J; Chen L; Shi S; Ji L
J Inorg Biochem; 2008 Aug; 102(8):1644-53. PubMed ID: 18468690
[TBL] [Abstract][Full Text] [Related]
12. Nickel-quinolones interaction. Part 5-Biological evaluation of nickel(II) complexes with first-, second- and third-generation quinolones.
Skyrianou KC; Perdih F; Papadopoulos AN; Turel I; Kessissoglou DP; Psomas G
J Inorg Biochem; 2011 Oct; 105(10):1273-85. PubMed ID: 21820989
[TBL] [Abstract][Full Text] [Related]
13. Interaction of Zn(II) with quinolone drugs: structure and biological evaluation.
Tarushi A; Polatoglou E; Kljun J; Turel I; Psomas G; Kessissoglou DP
Dalton Trans; 2011 Oct; 40(37):9461-73. PubMed ID: 21853189
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and DNA binding studies of new ruthenium(II)bisterpyridine complexes.
Sathyaraj G; Weyhermüller T; Nair BU
Eur J Med Chem; 2010 Jan; 45(1):284-91. PubMed ID: 19879670
[TBL] [Abstract][Full Text] [Related]
15. Organometallic ruthenium(II) complexes: synthesis, structure and influence of substitution at azomethine carbon towards DNA/BSA binding, radical scavenging and cytotoxicity.
Sathyadevi P; Krishnamoorthy P; Bhuvanesh NS; Kalaiselvi P; Vijaya Padma V; Dharmaraj N
Eur J Med Chem; 2012 Sep; 55():420-31. PubMed ID: 22901409
[TBL] [Abstract][Full Text] [Related]
16. Stepwise synthesis, characterization, DNA binding properties and cytotoxicity of diruthenium oligopyridine compounds conjugated with peptides.
Ypsilantis K; Plakatouras JC; Manos MJ; Kourtellaris A; Markopoulos G; Kolettas E; Garoufis A
Dalton Trans; 2018 Mar; 47(10):3549-3567. PubMed ID: 29436543
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, interaction with DNA, cytotoxicity, cell cycle arrest and apoptotic inducing properties of ruthenium(II) molecular "light switch" complexes.
Shobha Devi C; Anil Kumar D; Singh SS; Gabra N; Deepika N; Kumar YP; Satyanarayana S
Eur J Med Chem; 2013 Jun; 64():410-21. PubMed ID: 23665797
[TBL] [Abstract][Full Text] [Related]
18. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.
Egger A; Arion VB; Reisner E; Cebrián-Losantos B; Shova S; Trettenhahn G; Keppler BK
Inorg Chem; 2005 Jan; 44(1):122-32. PubMed ID: 15627368
[TBL] [Abstract][Full Text] [Related]
19. Nickel-quinolones interaction. Part 1 - Nickel(II) complexes with the antibacterial drug sparfloxacin: structure and biological properties.
Skyrianou KC; Efthimiadou EK; Psycharis V; Terzis A; Kessissoglou DP; Psomas G
J Inorg Biochem; 2009 Dec; 103(12):1617-25. PubMed ID: 19783053
[TBL] [Abstract][Full Text] [Related]
20. Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
Reisner E; Arion VB; Guedes da Silva MF; Lichtenecker R; Eichinger A; Keppler BK; Kukushkin VY; Pombeiro AJ
Inorg Chem; 2004 Nov; 43(22):7083-93. PubMed ID: 15500346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
